Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
5.61
+0.18 (3.31%)
Jun 12, 2026, 4:00 PM EDT - Market closed

IMDX Revenue

Insight Molecular Diagnostics had revenue of $32.00K in the quarter ending March 31, 2026, a decrease of -98.50%. This brings the company's revenue in the last twelve months to $1.95M, down -49.28% year-over-year. In the year 2025, Insight Molecular Diagnostics had annual revenue of $4.06M with 115.58% growth.

Revenue (ttm)
$1.95M
Revenue Growth
-49.28%
P/S Ratio
92.94
Revenue / Employee
$33,603
Employees
58
Market Cap
181.14M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.06M2.17M115.58%
Dec 31, 20241.88M378.00K25.15%
Dec 31, 20231.50M545.00K56.89%
Dec 31, 2022958.00K-1.24M-56.41%
Dec 31, 20212.20M982.00K80.76%
Dec 31, 20201.22M--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Myriad Genetics829.00M
OPKO Health581.12M
Castle Biosciences339.92M
Fulgent Genetics320.35M
Prenetics Global120.07M
MDxHealth110.97M
Biodesix96.10M
Burning Rock Biotech74.58M
Revenue Rankings